NCT02069639View on ClinicalTrials.gov

TARC After alloSCT in Hodgkin's Lymphoma

CompletedOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Hodgkin's Lymphoma Patients Who Underwent an Allogeneic Stem Cell Transplantation
Interventions
OTHER

no treatment

Trial Locations (1)

20133

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

All Listed Sponsors
lead

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

OTHER

NCT02069639 - TARC After alloSCT in Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter